Hepatocarcinoma measures the gene High _'s treatment of the rate of accuracy

Hepatocarcinoma measures the gene High _'s treatment of the rate of accuracy
So long as collect 5 ml of blood of human body, measure the screening of the gene through hepatocarcinoma, can make a definite diagnosis of and suffer from hepatocarcinoma. Shanghai has already developed hepatocarcinoma and measured genetic (MXR7) ,The mankind can be expected to be found and diagnosed correctly in early days while suffering from hepatocarcinoma, in order to be treated and cured effectively in time.
The hepatocarcinoma diagnostic method generally used at present is first child albumen measuring in the blood, but certain leaking the examining rate exists. And this kind diagnoses early hepatocarcinoma through the way that the gene add the image and study the method to measure to measure, the rate of accuracy can be more than 80%, is well-above first child albumen's detection rate, lead the world level.
Until hepatocarcinoma have any symptom behave in early days, now always when it has obvious symptoms that the upper abdomen pain appetite going from bad to worse, face difficult to endure wax yellow,etc. people, just go to the hospital to check whether one's own liver goes wrong, and at this moment once the liver of detection is problematic, also the later period while reaching. Use method to measure gene, people if liver have disease any, can sift, consult, find, diagnose in usual physical examination, can get the effective treatment if it is early, in order to lengthen lifespan, improve life quality.
Hepatocarcinoma measured the gene to obtain country and international monopoly. It is estimated in about 2~3 years, hepatocarcinoma can get extensive application on clinic when measuring the gene.
|